rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

BBB Foods Inc. Class A Common Shares

TBBB · NYSE

Consumer StaplesMass, Grocery & Drug RetailLeading

TBBB stood above a rising 150-day average in 51 of the last 52 weekly readings, including each of the last 50 weeks. It is 36.7% above that average now. Mass, Grocery & Drug Retail: 35% of its 26 stocks in an uptrend (±0 points in four weeks); Consumer Staples: 23% (+1 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
50 in a row
Industry in uptrend
35% 0 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$1.5M
Officials’ trades on record
0
Institutions holding
158 (+35)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 51 of 52 weeks.

20 Apr – 19 Oct
20%36%53%Apr 26Jun 26Jul 26Sep 26Oct 26

Mass, Grocery & Drug Retail: A minority of its stocks are in an uptrend and the share has held steady. Consumer Staples: A minority of its stocks are in an uptrend and the share has held steady.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1.5M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months2
Buyers · sellers0 · 1
WhoDidSharesTraded
Sapire Rose Nicole Dominique ReichDirectorsold7,623at $51.009 Sep 2026filed 11 Sep 2026
Sapire Rose Nicole Dominique ReichDirectorsold7,623at $50.502 Sep 2026filed 4 Sep 2026
Diego Ezequiel ApalateguiDirector of Sales & Operationssold133,336at $32.501 Jun 2026filed 3 Jun 2026
Sami Gabriel KhouriDirectorsold350,000at $32.501 Jun 2026filed 3 Jun 2026
Espinosa Eduardo PizzutoChief Financial Officersold180,000at $32.501 Jun 2026filed 3 Jun 2026
Kamal Anthony HatoumChairman & CEObought10,000at $32.501 Jun 2026filed 3 Jun 2026
Kamal Anthony HatoumChairman & CEOsold150,000at $32.501 Jun 2026filed 3 Jun 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders158+35 on the quarter
New · exited53 · 19
Reported value$2.8B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Capital International Investorsadded · filed 12 Aug 20267,526,848$313.6M+3,286,287+77.5%
FMR LLCadded · filed 13 Aug 20267,370,057$307.1M+1,165,247+18.8%
Orbis Allan Gray Ltdadded · filed 14 Aug 20266,735,036$280.6M+1,088,601+19.3%
Capital Research Global Investorsreduced · filed 12 Aug 20265,422,899$226.0M-422,416−7.2%
WASATCH ADVISORS LPadded · filed 10 Jul 20264,239,474$176.7M+139,649+3.4%
MORGAN STANLEYadded · filed 13 Aug 20263,977,125$165.7M+958,936+31.8%
GILDER GAGNON HOWE & CO LLCreduced · filed 14 Aug 20262,517,615$104.9M-36,609−1.4%
Route One Investment Company, L.P.added · filed 14 Aug 20262,224,201$92.7M+694,905+45.4%
PRINCIPAL FINANCIAL GROUP INCadded · filed 4 Aug 20262,070,499$86.3M+205,440+11.0%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLCadded · filed 13 Aug 20261,854,584$77.3M+185,689+11.1%
31 Mar 2024 – 30 Jun 2026
68112155Mar 24Sep 24Jun 25Dec 25Jun 26

Everyone who traded it

Sami Gabriel Khouri Company insiderDirector · last 14 Sep 20260 · 0
Sapire Rose Nicole Dominique Reich Company insiderDirector · last 9 Sep 20260 · 2
Diego Ezequiel Apalategui Company insiderDirector of Sales & Operations · last 7 Aug 20260 · 0
Espinosa Eduardo Pizzuto Company insiderChief Financial Officer · last 7 Aug 20260 · 0
Juan Pablo Cappello Company insiderDirector · last 7 Aug 20260 · 0
Kamal Anthony Hatoum Company insiderChairman & CEO · last 7 Aug 20260 · 0

Same industry

TGT TargetLeading+11%
FIVE Five BelowJust started moving+3%
GRDN Guardian Pharmacy ServicesJust started moving+2%
WMK Weis MarketsJust started moving+1%
CVS CVS HealthJust started moving+1%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

No ratio computed from its SEC filings yet.

Analyst forecasts

No analyst forecasts yet.